Skip to main content

Table 3 The model’s results considering the cumulative effect of new and generic drugs

From: New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)

  

2015

2016

2017

2018

2019

Number of patients

94,727

99,205

103,893

108,804

113,946

No new and generic drugs scenario

Total ART cost (€)

764,962,036

789,011,152

813,397,033

838,115,496

863,159,214

Per capita ART cost (€)

8,075

7,953

7,829

7,703

7,575

New and generic drugs scenario

Total ART cost (€)

760,408,704

772,152,627

794,021,079

787,013,681

752,848,759

Per capita ART cost (€)

8,027

7,783

7,643

7,233

6,607

Δ in total cost (€)

−4,553,331

−16,858,525

−19,375,954

−51,101,815

−110,310,454

% Δ in total cost

−0.6 %

−2.1 %

−2.4 %

−6.1 %

−12.78 %